Neuphoria Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.01

+0.02 (+0.38%)

As of Feb 8, 2:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +268.8% upside

Low Target $9.77

Average Target $14.79

High Target $16.23

Current Price $4.01

Current
$4.01

Target
$14.79

$9.77 $14.79 avg $16.23

Scenario Analysis

Bear Case

$9.77

143.6%

Low target

Base Case

$14.79

+268.8%

Avg target

Bull Case

$16.23

+304.7%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$15.06

-73.4% from high

52-Week Low

$9.72

+-58.7% from low

Target vs 52W High

$14.79

-1.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%